Abstract
Background:
Dural arteriovenous fistulas (DAVFs) in the Galen region are the most deeply located and most complex type of dural arteriovenous fistulas. However, cases of DAVFs in this region have not been well described. Thus, we aimed to summarize the characteristics of Galenic DAVFs involving clinical symptoms, anatomical architecture, and drainage patterns, providing experientially therapeutic strategies for these lesions based on our 20 years of clinical experience.
Methods:
We retrospectively examined 31 patients with Galenic DAVFs between January 2000 and June 2021. A comprehensive analysis was carried out based on the symptoms, imaging features, feeding arteries, draining veins, number and location of the fistulas, choice of treatment methods, and prognosis assessment.
Results:
Twenty-nine patients received endovascular embolization, and no perioperative deaths occurred. A transarterial approach was performed in 27 patients, and a combined transarterial and transvenous approach in one. And in one case, access was established by surgical drilling and embolization was done via the venous route. Twenty-four cases were completely obliterated after first embolization, and another five cases received a second period treatment. Only one patient developed cognitive dysfunction after embolization, and the outcomes of the remaining patients were improved at long-term follow-up.
Conclusion:
The understanding of symptoms of non-hemorrhagic neurological deficits in DAVF needs to be further clarified. Lesions with pial feeders may be considered first when determining surgical orders. Multi-approach and multi-stage embolization would be safe and effective. Excessive embolization and deep-vein system obstruction should be avoided. Approach creation by surgery would be an innovative interventional therapy.
Introduction
Dural arteriovenous fistulas (DAVFs) consist of abnormal arteriovenous interconnections in or around dural venous sinuses, as well as the meningeal veins or intradural pial veins (1–3). DAVFs account for 10–15% of all cerebrovascular malformations, which is one of the important causes of cerebral hemorrhage and neurologic deficits (1, 3). Given that they are positioned in the most complex and the deepest anatomical position, DVFs located in the Galenic region in adults (aGDAVFs) are uncommon.
Deep intracranial neurovascular relationships, especially the veins near the pineal and corpora quadrigemina region are the most complex. Deep cerebral veins, including the internal cerebral vein (ICV), the basal vein of Rosenthal (BVR) and their branches, mainly inflow to the vein of Galen, forming venous intersections and draining the deep venous system (DVS) (4). Reflux obstruction or venous hypertension in the drainage vein due to fistula formation can lead to specific and progressive symptoms. Non-hemorrhagic neurological deficits should be fully recognized for DAVFs (5). Accordingly, these symptoms need to be distinguished from cognitive dysfunction caused by degenerative diseases, otherwise misdiagnosis would lead to constant threats.
In this article, we present our interventional experience with aGDAVF treatment to evaluate angiographic findings, define its characteristics, and provide effective treatment strategies.
Methods
We retrospectively examined 31 patients with aGDAVFs who received treatment at the neurosurgery department of our hospital between January 2000 and June 2021. Retrospective analysis was carried out based on gender, age, initial and concomitant symptoms, imaging features, feeding arteries, draining veins, number and location of the fistulas, embolic strategies, and prognosis assessment.
Results
Patient profiles
In total, 31 patients were included in this work from January 2000 to June 2021, and a predominance in gender was revealed, for 25 men and six women were documented. The age range was from 23 to 73 years old.
Clinical presentation
Four patients suffered hemorrhagic neurological deficits, two of whom presented with subarachnoid hemorrhage (SAH, patients 5 and 16), and another two suffered intracerebral hemorrhage (ICH, patients 8 and 25). Clinical manifestations of cognitive impairment involving memory deterioration, computation ability impairment, lags in response, and mutism were accompanied by eight patients. Other symptoms such as headaches (12/31), tinnitus or cranial murmurs (4/31), ophthalmic signs (2/31), and limb weakness (9/31) were common in DAVF, and were also important factors influencing patients' health-related quality of life. Four patients had no obvious symptoms, and were found accidently through routine physical examination.
The main clinical manifestations are summarized in Table 1.
Table 1
| Case No. | Presentation | Cognition impairment | Cerebral hemorrhage | Clinical outcome | MRS score | |
|---|---|---|---|---|---|---|
| Pre- | Late- | |||||
| 1 | Asymptomatic | No. | No. | Asymptomatic | 0 | 0 |
| 2 | Tinnitus (right side) | No. | No. | Subsequently asymptomatic | 1 | 0 |
| 3 | Headache | No. | No. | Asymptomatic | 1 | 0 |
| 4 | Headache | No. | No. | Asymptomatic | 1 | 0 |
| 5 | Headache(SAH), Depression | No. | SAH | Subsequently asymptomatic | 5 | 1 |
| 6 | Headache, tinnitus (left side) | No. | No. | Asymptomatic | 2 | 0 |
| 7 | Conjunctival hyperemia, ocular protrusion (right side) | No. | No. | Ocular symptoms disappeared. | 2 | 0 |
| 8 | Cognitive impairment | Yes. | ICH | Previous symptoms relieved | 5 | 2 |
| 9 | Cognitive impairment, unsteadily walk | Yes. | No. | Previous symptoms relieved | 4 | 1 |
| 10 | Cognitive impairment, unsteadily walk | Yes. | No. | Previous symptoms relieved | 5 | 3 |
| 11 | Cognitive impairment, vision loss (left side) | Yes. | No. | Previous symptoms relieved | 3 | 1 |
| 12 | Cognitive impairment | Yes. | No. | Previous symptoms relieved | 4 | 3 |
| 13 | Cognitive impairment, memory deterioration, unsteadily walk | Yes. | No. | Previous symptoms relieved | 5 | 2 |
| 14 | Cognitive impairment, weakness of left limb | Yes. | No. | Previous symptoms relieved | 5 | 2 |
| 15 | Headache, intracranial murmurs, weakness of left limb | No. | No. | Previous symptoms remained. | 4 | 3 |
| 16 | Episodic headache with vomiting | No. | SAH | Previous symptoms relieved | 3 | 0 |
| 17 | Headache, intracranial murmurs | No. | No. | Asymptomatic | 2 | 0 |
| 18 | Headache, unsteadily walk | No. | No. | Asymptomatic | 3 | 0 |
| 19 | Asymptomatic | No. | No. | Asymptomatic | 0 | 0 |
| 20 | Headache | No. | No. | Previous symptoms relieved | 3 | 1 |
| 21 | Headache | No. | No. | Subsequently asymptomatic | 3 | 1 |
| 22 | Headache | No. | No. | Asymptomatic | 3 | 0 |
| 23 | Weakness of left limb | No. | No. | Asymptomatic | 3 | 0 |
| 24 | Asymptomatic | No. | No. | Asymptomatic | 0 | 0 |
| 25 | Sudden unconsciousness | No. | ICH | Subsequently asymptomatic | 5 | 2 |
| 26 | Unsteadily walk | No. | No. | Subsequently asymptomatic | 2 | 0 |
| 27 | Asymptomatic | No. | No. | Asymptomatic | 0 | 2 |
| 28 | Headache | No. | No. | Subsequently asymptomatic | 1 | 0 |
| 29 | Cognitive impairment, weakness of lower limbs | Yes. | No. | Previous symptoms relieved | 3 | 2 |
| 30 | Asymptomatic | No. | No. | Asymptomatic | 0 | 0 |
| 31 | Numbness of left upper limb | No. | No. | Subsequently asymptomatic | 1 | 0 |
Clinical presentations, angiographic and clinical outcomes and MRS scores.
Angiographic architecture
DAVFs in the Galenic region are complex, for they are often supplied by multiple arterial systems (external carotid system, internal carotid system, and vertebral artery system). As we documented in all 31 cases, 24 received blood supply from all systems simultaneously, six were supplied by two systems at least, and only one was supplied by the external carotid system. The dominant suppliers were from external carotid artery (ECA) system, as middle meningeal artery (MMA) (24/31) and occipital artery (OA) (20/31) were the main feeders. Other suppliers involving superficial temporal artery (STA) (7/31 patients, 22.6%), ascending pharyngeal artery (APA) (1/31) and internal maxillary artery (IMA) (2/31), together with their miscellaneous branches (1/31) contributed to a lesser degree. Feeding arteries originating from the internal carotid artery (ICA) system mainly included the meningohypophyseal trunk (MHT) (12/31), ophthalmic artery (OphA) (4/31 patients), pericallosal artery (2/31), anterior choroidal artery (AChA) (1/31), as well as ICA branches (1/31 patients) also participated in this kind of blood supply. Posterior meningeal artery (PMA) (7/31), posterior cerebral artery (PCA) (13/31) and superior cerebellar artery (SCA) (11/31) were the common feedings from the vertebral artery (VA) system, and a few feeders also originated from VA branches (6/31), the posterior medial choroid artery (MPChA) (4/31), and posterior lateral choroid artery (LPChA) (1/31).
Enlarged drainage veins with venous lake formation were typical angiographic features, since huge venous lakes in 18 patients of the 31 could be clearly seen via angiography. Supratentorial drainages were the main outflow routes, involving ICV, BVR and internal occipital vein, etc. The straight sinus was also an important outflow tract, reaching the transverse sinus, sigmoid sinus. Fistulas with cortical venous drainage could also drain into the superior sagittal sinus. Only one fistula drained by superior veins of cerebellar hemisphere (the patient 19).
Detailed angiographic architectures and interventional features were listed in Table 2.
Table 2
| Case No. | Feeders | Draining veins | Cornard classification | Venous lake | Main approaches | Embolic agents | Treatment Stage |
|---|---|---|---|---|---|---|---|
| 1 | L PMA, R MMA, L MHT | Straight sinus, superior sagittal sinus | IIa+b | No | R MMA | ONYX 18 | 1 |
| 2 | R MHT, Bi MMAs, Bi STAs, Bi OAs, L PChA, L SCA | Straight sinus, VoG-BVR-cavernous sinus | IIa+b | Yes | R ICA, R ECA | ONYX 18 | 1 |
| 3 | R OphA, L MMA, L PMA, L OAs | Tentorial sinus, falcine sinus, suboccipital venous plexus | IIa+b | Yes | L MMA, L PMA | NBCA | 1 |
| 4 | Bi OphAs, Bi PMAs, Bi OAs, Bi MMAs, L SCA | Straight sinus, ICV | IIa | Yes | L OphA, R PMA, L OA, Bi MMAs | ONYX 18 | 1 |
| 5 | Bi LPChAs, L OA, L PMA | Straight sinus | IIa | No | L PCA | ONYX 18 | 1 |
| 6 | Bi MHTs, R ECA, R MMA, L PChA, Bi PCAs | Straight sinus, superior sagittal sinus | IIa+b | Yes | L PChA, Bi MMAs, R PICA | ONYX 18+ Glubran+ Coils | 2 |
| 7 | L MHT, Bi MMAs, L IMA, Bi PCAs, Bi OAs, L PMA, Bi SCAs, | Straight sinus, VoG-BVR-cavernous sinus-sylvian vein and angular vein | IIa+b | Yes | L MMA, L angular artery | ONYX 18 +NBCA+Coils | 2 |
| 8 | R MMA, L SCA | Straight sinus, superior sagittal sinus | IIa+b | No | R MMA | NBCA | 1 |
| 9 | Bi OAs, R MMA, L SCA, R pericallosal artery | Straight sinus, superior sagittal sinus | IIa+b | Yes | R MMA | ONYX 18 | 2 |
| 10 | R MMA | ICV, BVR, falcine sinus | IIa | No | R MMA | ONYX 18 | 1 |
| 11 | Bi MHTs, Bi MMAs, R PCA | Straight sinus, BVR | III | Yes | Bi MMAs | ONYX 18 | 1 |
| 12 | R PCA, R OA, R MMA | ICV, BVR, cortical vein of occipital lobe | IIa+b | No | R PCA, Bi MMAs | ONYX 18 | 1 |
| 13 | L ECA | ICV, BVR, straight sinus | IIa+b | No | L STA | ONYX 18 | 1 |
| 14 | Bi MMAs, Bi STAs, Bi OAs, Bi MHTs, Bi VAs | Straight sinus, superior sagittal sinus | IIa+b | Yes | R ECA, L MMA | ONYX 18+ONYX 34 | 2 |
| 15 | Bi ICAs, Bi ECAs, Bi VAs | Straight sinus, ICV-BVR-cavernous sinus | IIa+b | Yes | - | - | - |
| 16 | R MHT, Bi MMAs, Bi OAs, R STA, Bi PCAs | Straight sinus, falcine sinus | IIa | No | R LPChA, R MMA, L SCA | NBCA | 1 |
| 17 | Bi MMAs, Bi OAs, Bi STAs, L APA, L OphA, L MHT | Straight sinus | IIa+b | Yes | Bi MMAs, Bi OAs, L APA | ONYX 18+Glubran | 1 |
| 18 | Bi SCAs, L MPChA | BVR-cavernous sinus, sylvian vein-superior sagittal sinus | IIa+b | No | R SCA, L MPChA | ONYX 18 | 1 |
| 19 | Bi SCAs, L PCA, L VA, L OA | ICV, BVR, veins of cerebellar hemisphere | IIa | No | - | - | - |
| 20 | L MPChA, Bi MMA, branches of L VAs | Straight sinus, superior sagittal sinus | III | Yes | L MPChA, R MMA | Glubran | 1 |
| 21 | Bi MMAs, Bi OAs, L pericallosal artery, L SCA | Straight sinus, superior sagittal sinus | IIa+b | Yes | L ACA, L MMA | ONYX 18 | 1 |
| 22 | Bi OAs, Bi MHTs, Bi PCAs, Bi SCAs | Straight sinus | IV | No | R OA | ONYX 18 | 1 |
| 23 | Bi MMAs, Bi OAs, R AchA, Bi PMAs, Bi PCAs, L SCA | Straight sinus | IV | Yes | L PMA, L SCA, L PCA, Bi OAs, Bi MMAs, Bi MPChAs | ONYX 18 | 2 |
| 24 | Bi MHTs, Bi OAs, Bi MMAs, Bi PCAs, Bi MPChAs | Straight sinus | IV | No | L MPChA, R ECA | ONYX 18+Glubran +balloon | 1 |
| 25 | R MMA, Bi OAs, Bi PCAs | Straight sinus | III | No | Bi PCAs, R MMA | Glubran | 1 |
| 26 | Bi PCAs, L MMA, L STA, L OA | Straight sinus | III | Yes | R PCA, R MPChA | ONYX 18+Glubran | 1 |
| 27 | Bi MMAs, Bi OAs, Bi MHTs, R PMA,L IMA, L MPChA | Straight sinus, BVR | IIa | Yes | L MPChA, L MMA | ONYX 18+Glubran | 1 |
| 28 | Bi STAs, Bi OAs, R MMA, R OphA, Bi PCAs, Bi SCAs | Straight sinus | III | Yes | R MMA | ONYX 18 | 1 |
| 29 | Bi MMAs, Bi PCAs, R STA | Straight sinus | IIa | Yes | R MMA | ONYX 18 | 1 |
| 30 | Bi MHTs, Bi MMAs, Bi VAs | Straight sinus | IIa+b | Yes | L MMA | ONYX 18+Coils | 1 |
| 31 | L OA, L VA | Straight sinus, ICV | IIa | No | R OA | ONYX 18 | 1 |
Angiographic characteristics and treatment technique.
Treatment strategies
For exhaustive evaluation of anatomic architecture, total cerebral angiography should be done through VA, ICA, and ECA of both sides.
Then, the following embolic strategies can be considered. First, priority should be given to obliterate pial feeders with soft microcatheters. Second, to place the catheter in the optimum position, surgical pathways could be established (as the patient 7, described in Figure 1). Thirdly, DMSO-based liquid embolic agents might be the main choice, while the agent's polymerization speed and dispersion properties should be considered. Any excessive embolization is not expected. Other materials including coils, auxiliary stents, and balloons can be considered if necessary. Lastly, in preoperative or intraoperative evaluation, a multistage embolization strategy is feasible if complete embolization could not be fulfilled by a single operation. Patients 6, 7, 9, 14, and 23 (described in Table 2) received two stages of treatment to avoid probable complication risks following a single complete occlusion (Details are described in the discussion section).
Figure 1
Outcomes
In all 31 patients, only two declined to receive interventional treatment. Beyond that, 29 patients received endovascular embolization, and no perioperative death occurred. Seventeen patients had no observable symptoms after treatment, and eight patients had mild symptoms without any impacts on normal life and work. However, only four patients showed slight improvement after treatment when compared with the preoperative level: two patients' poor outcomes may be attributed to initial severe intracranial hemorrhage stroke (patients 10 and 29), and another five patients suffered severe cognitive disorders, all of which resulted in poor prognosis. Notably, only one patient developed cognitive dysfunction within 2 weeks of surgery, and postoperative magnetic resonance images suggested thalamic infarction (patient 27 described in Figure 2).
Figure 2
Obviously, cognitive impairment could be an important factor affecting prognosis, and occurred in eight of the 31 patients before treatment. Specific symptoms, including memory impairment, attention deficit, and emotional lability, were prominent manifestations. Among the eight patients with varying degrees of cognitive impairment, one was treated conservatively with an unfavorable prognosis, and seven underwent interventional treatment. Cognitive impairment persisted in the seven treated patients, suggesting that the long course of the disease may have resulted in pathological irreversibility. The median duration of long-term follow-up was 24 months (ranging from 12 to 96 months). All patients were followed up with imaging examination involving MRI and DSA, or through telephone for follow-up, the outcomes' grades according to modified Rankin Scale (mRS) were summarized in Table 1.
Discussion
From the pathophysiological and therapeutic perspective, there are unique angioarchitectural characteristics of aGDAVFs, which are mainly derived from their location and venous drainage. Interesting points are discussed to comprehensively understand this nidus and to share the optimal treatment options.
Definition and general description
AGDAVFs are the most complex type of DAVF, and are difficult to manage because of their deep location and unusual vascularity. Except for some case reports or series, aGDAVFs have seldom been reported as a separate type of DAVF, and there was no specific management guidance on aGDAVFs from the endovascular treatment perspective (6). In Lawton's work, as a type of tentorial DAVFs, seven cases of DAVF at the Galenic region were reported, which were removed by surgery (7). A few cases that were not clearly defined were also recorded in previous documents (8, 9). As Lawton described, GDAVF were located in the midline at the posterior margin of the tentorial incisura, and the vein of Galen entered the anterior falcotentorial junction. Supratentorial and/or infratentorial venous drainages could be found. Notably, to define the lesion in this area and describe its characteristics more accurately, it would be of significance to make sure the cases are pure DAVFs but not vein of Galen arteriovenous malformations (VGAMs). VGAMs typically occur in young children and are described as occurring from the 6th and 8th to 11th weeks of gestation (10). Depending on the occurrence or absence of venous anatomy development at these stages, venous drainage from VGAMs is variable, with many potential outflow routes. Lasjaunias et al. described this lesion in detail and established various classifications of VGAMs (11–13). However, since these defects are so rare, malformations that drain into the Galen vein or nearby venous system, as well as those with Galen vein thickening and venous lake formation, were often described as VGAMs in the literature, without specifying the venous characteristics of the DAVF in the Galen region. Some clear descriptions about its characteristics are listed as follows: (1) The supply by meningeal arteries, especially from the ECA, is usually dominant, and simultaneous suppliers from multiple systems are common, as mixed pial and dural feeders are often found. (2) The number of fistulas varies greatly, and the majority of patients may have numerous fistulas and are distributed distinctively. (3) Abnormal venous enlargement with venous lake formation are common angiographic findings.
Anatomy of the Galen area and its tributaries
The Galen vein is located in an important anatomical structure of the quadrigeminal cistern in the deep brain, which lies between the atrial portion of the paired choroidal fissures (14, 15). Five walls (one superior, one inferior, one anterior, and two lateral) contribute to the configuration of the cistern (4).
The roof (superior wall) and the floor (inferior wall) are formed by the lower surface of the splenium of the corpus callosum and the super-oventral portion of the cerebellum respectively. The anterior wall is the corpora quadrigemina, also known as two paired superior and inferior colliculus, and the pineal body lies between the paired superior colliculi. The two symmetrical lateral walls are composed of the fornix crus and the occipital cortex. The Galen vein drained into the straight sinus. Accordingly, we call this area, including the vein of Galen with its draining veins and branches, as well as the surrounding structures, the region of Galen.
Vein tributaries of the Galen region are complex (16, 17). The pineal and tectal veins drain into anterosuperior aspect of the vein of Galen. The SVV and the PCV or SCV, encountered from posterior to anterior, drain into its posteroinferior side. The ICVs are the main anterior veins, and they join to form the vein of Galen. Meanwhile, from the two lateral sides, the basal vein (BV) drains into the Galen vein. Remarkably, the ICVs and BVs are recognized as the major origin of the Galen vein.
Since these veins are closely related to the function of surrounding brain regions, thrombosis formation and embolic sacrifice, which decreased the potential for collateral formation, may lead to the serious consequences (16). In line with this, cortical veins reflux and venous hypertension would occur, as the ICV and BV reverse their flows and drain backwards when the normal drainage pathways are interrupted. Moreover, the straight sinus is the unique normal outlet of Galen vein, and its patency is often related to the function of the deep venous system (DVS) (3). Interventional treatment should ensure that the DVS is unblocked as much as possible, and the sacrifice of any vein should be considered carefully, especially in the straight sinuses (18, 19).
Characteristic clinical signs
In recent years, with the promotion of national health awareness, the number of asymptomatic patients with DAVF is gradually increasing. Five patients in our study had no warning signs prior to their hospital visit (patients 1, 19, 24, 27, and 30), and anomalies were incidentally discovered through physical examination. However, the majority of patients still have symptoms. Currently, the presentations of intracranial galenic DAVF could be generalized into three categories: (1) Symptoms of pulsatile tinnitus, intracranial vascular murmur and ophthalmological phenomenon causing by the increased dural sinus drainage; (2) ICH and subsequent neurological deficits; and (3) Non-hemorrhagic neurological deficits (NHNDs), which need to be further recognized. Of course, most of these symptoms are strongly related to drainage patterns, especially the presence or absence of cortical veins drainage (20, 21).
Notably, in the present work, we mainly emphasize the description of progressive dementia, which is an under-recognized sign of DAVFs. Thanks to the improvement in imaging and analytical techniques, cortical venous hypertension induced thalamic dementia could be correctly diagnosed and treated, though DAVFs are one of a number of conditions that can cause thalamic dementia (22). However, patients who suffer the deep venous system thrombosis, infectious and toxic insults, metabolite deposition and osmotic myelinolysis, and even occupying tumors in this region may share similar symptoms as the pathological conditions of the thalami (5, 23). Thus, a thorough clinical history may provide strong clues when distinguishing these numerous etiologies, for various pathogenic factors may have certain characteristics. Furthermore, neuroimaging techniques such as MRIs can further enhance the identification of these possible causes. In most situations, progressive dementia associated with aGDAVF is usually visible on an MRI as bilateral thalamic high signal on T2/FLAIR sequences (24–26).
However, variability in these signal characteristics is not uncommon (27, 28). The complex or unclear image signals may lead to an unclear diagnosis, which may cause delays in treatment. More importantly, just as in our study, not all patients with obvious dementia symptoms have typical imaging findings. Thus, we suggest that the use of MRIs and angiographies such as DSA are both necessary for undetermined progressive dementia. Our results suggest that cognitive dysfunction may be very hard to reverse, so timely diagnosis and effective treatment are necessary to stop the deterioration process.
Endovascular intervention
According to the architecture and hemodynamic characteristics of the DAVF in the Galenic region, we summarized applicable embolization strategies that were optimal to enhance their safety and effectiveness, as well as to reduce complications.
Firstly, DAVFs with pial arterial feeders, which are also called mixed DAVFs, have rarely been documented (29). However, the risk caused by pial artery supplied fistula during the endovascular treatment might not be fully appreciated. Since the pial feeding arteries are often tortuous, tenuous, and fragile, the process of super-selective catheterization is difficult, with increasing bleeding risk (29–31). An effective strategy is to deal with these feeders first before the fistula embolization is suggested. As conventional, multi-stage endovascular embolization is acceptable when one single complete embolization is predicted to increase operational risk. Furthermore, skillful and gentle handling with optimal materials is highly advisable, avoiding hemorrhagic complications from an interventional operation.
Second, the options of approaches and materials are commonly considered when treating DAVFs by endovascular intervention, while transarterial fluid embolization is primarily recommended (32–34). Fluid agents including Onyx, NBCA (n-butyl cyanoacrylate) and Glubran were mainly used in our cases. The characteristics of these liquid embolic agents are briefly summarized as follows: (1) Onyx glue is an ideal material for endovascular embolization in the treatment of dural arteriovenous fistula. Before using it, Onyx needs to be shaken with dimethyl-sulfoxide (DMSO) and tantalum powder for about 20 min to form a polymer suspension. Then Onyx gradually forms embolization from the periphery to the inner core, which may take about 10 min. Onyx has a better mechanical filling effect, so it is suitable for embolization of more complex fistulas. At the same time, Onyx releases less heat in the embolization process, so the probability of postoperative inflammation is lower. (2) The embolization of NBCA formed in the blood vessel is permanent, and it has a beneficial effect on the embolization of large blood vessels with its outstanding mechanical strength. However, before injection, the microcatheter needs to be rinsed with a non-ionic 5% glucose solution to prevent premature intraductal embolization. At the same time, the microcatheter should be removed in time after glue injection to prevent the hardening substance from embolizing in the microcatheter. All of these procedures require a skilled surgeon and the help of a qualified assistant. On the other hand, for delicate blood vessels, NBCA embolization agents are difficult to penetrate completely. Moreover, when complex lesions require multiple embolizations, it cannot be achieved with NBCA alone. (3) Glubran glue (NBCA-MS, 2-methylstyrene-α-isobutyl cyanoacrylate) is a kind of adherent liquid embolization material produced on the basis of the original NBCA. Its polymerization time is extended from 15–40 s (NBCA glue) to 60–90 s, which provides a sufficient time window for full and uniform embolization. It also avoids the risk of microcatheter adhesion caused by premature polymerization, resulting in difficult catheter removal and even bleeding.
Compared with Onyx, Glubran is thought to diffuse faster and regurgitate less during embolization, which allows easier catheter removal. In general, to achieve perfect embolization and minimize the occurrence of complications with liquid embolic agents, the selection of injection-related vessels, the concentration of glue, and the speed of injection are crucial. In addition, to prevent the agents migrating into the perforating vessels of the thalamus, the rapid polymerization property of the agents should be considered (34).
Advances in materials science and technology have encouraged us to eliminate the culprit both in symptoms and anatomy. In addition, the pressure cooker, balloon-assisted embolization, and multi-plug techniques were widely applied to enable the liquid agent to flow forward and penetrate without reflux (35–38). All these measures could be taken to achieve the most distal embolization without accident complication.
Third, complete fistula embolization should be performed while conserving the patency of the DVS as much as possible. Excessive venous occlusion could be the main reason for unexpected complications such as progressive thrombosis and venous-related infarcts post-embolization (6). As the cautionary case in Figure 2 shows, although there were no inappropriate steps throughout the embolization procedure, the postoperative angiography suggested the intravenous outflow time of contrast agent was delayed, which might indicate excessive embolization. The MRI scan showed bilateral thalamus infarction, which may explain the cognitive dysfunction of the patient. On the other hand, occlusion of the venous component that is too early may result in bleeding. When the sacrifice of a vein is inevitable, a clear understanding of vascular anatomy and draining patterns is strongly needed. Any haphazard attempts at venous sacrifice may result in serious complications. The straight sinus should be protected as much as possible, ensuring the venous outflow of Galen is unobstructed. Although it is unclear whether it may be beneficial to try to unblock the straight sinus, interventional occlusion is not encouraged if it is unobstructed before surgery.
Lastly, due to extremely tortuous feeders, super-selective catheterization failing to reach a fistula is possible. Thereby, pathway creation through a transosseous approach may be a valuable strategic option to overcome this limitation (39–42). In very specific cases, as we described in Figure 1, when endovascular access is not possible, direct external occipital protuberance puncture was shown to be feasible and effective. With the development of related assistive techniques including intraoperative navigation, ultrasound-guided procedures, and three-dimensional reconstructed imaging, the safety of such operations would be greater.
Conclusion
Our work recorded the largest number of aGDAVF cases to date, emphasizing the unique angioarchtecture as an individual entity. The symptoms of progressive dementia need to be further recognized. With a high risk of aggressive clinical course, early diagnosis and timely intervention is crucial for a good prognosis. Pial-first transarterial embolization is suggested. Excessive embolization with deep vein system obstruction is not recommended. Surgical path creation is encouraged when conventional approaches cannot not be undertaken satisfactorily. Based on the detailed understanding of anatomical architectures and drainage patterns, aGDAVFs can be embolized safely and effectively by judicious endovascular interventional strategies.
Funding
This study was funded by National Natural Science Foundation of China (Award Number: 82101460).
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Statements
Data availability statement
The raw data supporting the conclusions of this article will be made available by the authors, without undue reservation.
Ethics statement
The studies involving human participants were reviewed and the study was approved by Ethics Committee of Xuanwu Hospital of Capital Medical University. The patients/participants provided their written informed consent to participate in this study.
Author contributions
TT analyzed the data, drafted the manuscript, and arranged ideas. ZS collected the data and contributed to the analyzation. YM revised the manuscript and designed the key points of writing. CY participated in data collection. CH, GL, TH, LS, and PH guided the operation and controlled the operation steps. PZ, MY, and HZ performed operations, designed the concept, and approved the paper for publication. All authors made critical revisions of the manuscript and reviewed the final version.
Conflict of interest
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. The handling editor LM, declared a shared parent affiliation with the authors at the time of review but no collaboration or relationships with the authors.
- ECA
external carotid artery
- ICA
internal carotid artery
- VA
vertebral artery
- MMA
middle meningeal artery
- OA
occipital artery
- STA
superficial temporal artery
- APA
ascending pharyngeal artery
- PAA
posterior auricular artery
- IMA
internal maxillary artery
- MHT
the meningohypophyseal trunk
- OphA
ophthalmic artery
- ACA
anterior cerebral artery
- MCA
middle cerebral artery
- AChA
anterior choroidal artery
- PMA
posterior meningeal artery
- PCA
posterior cerebral artery
- SCA
superior cerebellar artery
- MPChA
medial posterior choroidal artery
- LPChA
lateral posterior choroidal artery
- ICV
internal cerebral vein
- BVR
the basal vein of Rosenthal
- IJV
internal jugular veinc
- DVS
deep venous system
- SVV
superior vermian vein
- PCV
precentral cerebellar vein
- SCV
superior cerebellar vein
- aGDAVF
Adult Galenic Dural Arteriovenous Fistula
- ICU
intensive care unit
- mRS
modified Rankin Scale
- NHNDs
Non-hemorrhagic neurological deficits.
Abbreviations
References
1.
NewtonTHCronqvistS. Involvement of dural arteries in intracranial arteriovenous malformations. Radiology. (1969) 93:1071–8. 10.1148/93.5.1071
2.
BrownRDJrFlemmingKDMeyerFBCloftHJPollockBELinkML. Natural history, evaluation, and management of intracranial vascular malformations. Mayo Clin Proc. (2005) 80:269–81. 10.4065/80.2.269
3.
IslakCBagcilarONacar DoganSKorkmazerBArslanSKizilkilicOet al. Endovascular management of anterior falcotentorial dural arteriovenous fistulas: importance of functionality of deep venous system and existence of accompanying choroidal arteriovenous malformation. J Neurointerv Surg. (2021) 14:599–604. 10.1136/neurintsurg-2021-017730
4.
ChaynesP. Microsurgical anatomy of the great cerebral vein of Galen and its tributaries. J Neurosurg. (2003) 99:1028–38. 10.3171/jns.2003.99.6.1028
5.
HolekampTFMollmanMEMurphyRKKolarGRKramerNMDerdeynCPet al. Dural arteriovenous fistula-induced thalamic dementia: report of 4 cases. J Neurosurg. (2016) 124:1752–65. 10.3171/2015.5.JNS15473
6.
PaulLCasascoAGilAAleuAGuimaraensL. Arteriovenous fistulas of the Vein of Galen region in adults: Endovascular treatment. Interv Neuroradiol. (2020) 26:757–66. 10.1177/1591019920940495
7.
LawtonMTSanchez-MejiaROPhamDTanJHalbachVV. Tentorial dural arteriovenous fistulae: operative strategies and microsurgical results for six types. Neurosurgery. (2008) 62:110–24; discussion 124–5. 10.1227/01.neu.0000317381.68561.b0
8.
FournierDRodeschGTerbruggeKFlodmarkOLasjauniasP. Acquired mural (dural) arteriovenous shunts of the vein of Galen. Report of 4 cases. Neuroradiology. (1991) 33:52–5. 10.1007/BF00593335
9.
YajimaHShinyaYHasegawaHShinMUekiKKawashimaMet al. Peculiar Characteristics of Arteriovenous Malformations Arising in the Galenic Region. Diagnostics (Basel). (2020) 10:481. 10.3390/diagnostics10070481
10.
KhullarDAndeejaniAMBulsaraKR. Evolution of treatment options for vein of Galen malformations. J Neurosurg Pediatr. (2010) 6:444–51. 10.3171/2010.8.PEDS10231
11.
CampiARodeschGScottiGLasjauniasP. Aneurysmal malformation of the vein of Galen in three patients: clinical and radiological follow-up. Neuroradiology. (1998) 40:816–21. 10.1007/s002340050691
12.
LasjauniasPRodeschGPruvostPLarocheFGLandrieuP. Treatment of vein of Galen aneurysmal malformation. J Neurosurg. (1989) 70:746–50. 10.3171/jns.1989.70.5.0746
13.
WatbanJARodeschGAlvarezHLasjauniasP. Transarterial embolization of vein of Galen aneurysmal malformation after unsuccessful stereotactic radiosurgery. Report of three cases. Childs Nerv Syst. (1995) 11:406–8. 10.1007/BF00717406
14.
RhotonALJrYamamotoIPeaceDA. Microsurgery of the third ventricle: Part 2. Operative approaches. Neurosurgery. (1981) 8:357–73. 10.1227/00006123-198103000-00007
15.
YamamotoIRhotonALJrPeaceDA. Microsurgery of the third ventricle: Part I. Microsurgical anatomy. Neurosurgery. (1981) 8:334–56. 10.1227/00006123-198103000-00006
16.
OnoMRhotonALJrPeaceDRodriguezRJ. Microsurgical anatomy of the deep venous system of the brain. Neurosurgery. (1984) 15:621–57. 10.1227/00006123-198411000-00002
17.
OnoMOnoMRhotonALJrBarryM. Microsurgical anatomy of the region of the tentorial incisura. J Neurosurg. (1984) 60:365–99. 10.3171/jns.1984.60.2.0365
18.
Ben-DovMInbarESteinerI. Cerebral straight sinus thrombosis: an unusual cause of confusion. JAMA Neurol. (2015) 72:1527. 10.1001/jamaneurol.2015.2282
19.
SmajdaSSodermanMDorfmullerGDorisonNNgheMCRodeschG. Endovascular management of torcular dural sinus malformations in children: the role of straight sinus occlusion. J Neurointerv Surg. (2021) 13:278–83. 10.1136/neurintsurg-2020-016888
20.
ReynoldsMRLanzinoGZipfelGJ. Intracranial dural arteriovenous fistulae. Stroke. (2017) 48:1424–31. 10.1161/STROKEAHA.116.012784
21.
BultersDOMathadNCullifordDMillarJSparrowOC. The natural history of cranial dural arteriovenous fistulae with cortical venous reflux–the significance of venous ectasia. Neurosurgery. (2012) 70:312–8; discussion 318–9. 10.1227/NEU.0b013e318230966f
22.
CarreraEMichelPBogousslavskyJ. Anteromedian, central, and posterolateral infarcts of the thalamus: three variant types. Stroke. (2004) 35:2826–31. 10.1161/01.STR.0000147039.49252.2f
23.
AmeridouISpiliotiMAmoiridisG. Bithalamic infarcts: embolism of the top of basilar artery or deep cerebral venous thrombosis?Clin Neurol Neurosurg. (2004) 106:345–7. 10.1016/j.clineuro.2004.01.004
24.
TanakaKMorookaYNakagawaYShimizuS. Dural arteriovenous malformation manifesting as dementia due to ischemia in bilateral thalami. A case report. Surg Neurol. (1999) 51:489–93; discussion 493–4. 10.1016/S0090-3019(98)00020-2
25.
TamamotoFNakanishiATakanashiTIshizakiHNagasawaHMaeharaTet al. Unexpected accumulation of thallium-201 in bilateral thalamic venous infarction induced by arteriovenous fistula in the posterior fossa: report of a case. Ann Nucl Med. (2003) 17:239–43. 10.1007/BF02990028
26.
DehdashtiARMatoukCCTerbruggeKWallaceMCWillinskyRA. Clues to dural arteriovenous fistulas in patients with progressive dementia. Can J Neurol Sci. (2010) 37:532–4. 10.1017/S0317167100010611
27.
WaragaiMTakeuchiHFukushimaTHaisaTYonemitsuT. MRI and SPECT studies of dural arteriovenous fistulas presenting as pure progressive dementia with leukoencephalopathy: a cause of treatable dementia. Eur J Neurol. (2006) 13:754–9. 10.1111/j.1468-1331.2006.01318.x
28.
BellDADavisWLOsbornAGHarnsbergerHR. Bithalamic hyperintensity on T2-weighted MR: vascular causes and evaluation with MR angiography. AJNR Am J Neuroradiol. (1994) 15:893–9.
29.
GhaliMGZArboreliusUPVeznedarogluESpetzlerRFYasargilMGMarchenkoV. Galenic pial arteriovenous fistulas in adults. J Neurol Sci. (2020) 416:117014. 10.1016/j.jns.2020.117014
30.
GuptaAKRaoVRVarmaDRKapilamoorthyTRKesavadasCKrishnamoorthyTet al. Evaluation, management, and long-term follow up of vein of Galen malformations. J Neurosurg. (2006) 105:26–33. 10.3171/jns.2006.105.1.26
31.
George Zaki GhaliM. Galenic pial arteriovenous fistulas: Angioarchitecture, clinical presentation, therapeutic considerations. Clin Anat. (2018) 31:259–68. 10.1002/ca.23004
32.
LordJBrittonHSpainSGLewisAL. Advancements in the development on new liquid embolic agents for use in therapeutic embolisation. J Mater Chem B. (2020) 8:8207–18. 10.1039/D0TB01576H
33.
de Castro-AfonsoLHTrivelatoFPRezendeMTUlhoaACNakiriGSMonsignoreLMet al. Transvenous embolization of dural carotid cavernous fistulas: the role of liquid embolic agents in association with coils on patient outcomes. J Neurointerv Surg. (2018) 10:461–2. 10.1136/neurintsurg-2017-013318
34.
VollherbstDFChapotRBendszusMMohlenbruch MGlueA. Onyx, squid or PHIL? Liquid embolic agents for the embolization of cerebral arteriovenous malformations and dural arteriovenous fistulas. Clin Neuroradiol. (2021) 32:25–38. 10.1007/s00062-021-01066-6
35.
PulliBSussmanESMayercikVSteinbergGKDoHMHeitJJ. Initial experience with the Scepter Mini dual-lumen balloon for transophthalmic artery embolization of anterior cranial fossa dural arteriovenous fistulae. J Neurointerv Surg. (2020) 12:1132–6. 10.1136/neurintsurg-2020-016013
36.
SahuCDBhargavaN. Intra-arterial onyx embolisation of sphenobasilar sinus fistula using pressure cooker technique: case report and review of the literature. Neuroradiol J. (2021) 34:131–4. 10.1177/1971400920972512
37.
ClarenconFStrackeCPShotarEWallochaMMosimannPJBochALet al. Pressure cooker technique for endovascular treatment of spinal arteriovenous fistulas: experience in 15 cases. AJNR Am J Neuroradiol. (2021) 42:1270–5. 10.3174/ajnr.A7078
38.
CekirgeHSSaatciI. Republished: multiplug flow control technique as a novel transarterial curative approach for the endovascular treatment of cerebrovascular malformations. J Neurointerv Surg. (2021) 14:1–3. 10.1136/bcr-2021-017418
39.
TrivelatoFPManzatoLBFilhoPMMUlhoaACVanzinJRAbudDGet al. Transorbital cavernous sinus direct puncture : alternative to treat dural arteriovenous fistula. Clin Neuroradiol. (2018) 28:55–61. 10.1007/s00062-016-0534-z
40.
CavalcantiDDRazEShapiroMMirONossekENelsonPK. Percutaneous transorbital direct puncture to obliterate a cavernous sinus dural arteriovenous fistula. J Neurointerv Surg. (2021) 13:1190. 10.1136/neurintsurg-2020-017118
41.
DiazOMToledoMMRoehmJOFKlucznikRPChinnaduraiPLopezGVet al. Unique percutaneous direct puncture technique for occlusion of a hypoglossal canal dural arteriovenous fistula. J Neurointerv Surg. (2018) 10:1179–82. 10.1136/neurintsurg-2018-013845
42.
ClarenconFShotarEPouvelleAMouyalSLenckSPrematKet al. Direct puncture of the superficial temporal artery for ethylene vinyl alcohol embolization of a type 3 arteriovenous fistula with a dual lumen balloon. J Neurointerv Surg. (2021) 13:493. 10.1136/neurintsurg-2020-016351
Summary
Keywords
dural arteriovenous fistula, Galenic area, endovascular management, cognitive dysfunction, progressive dementia
Citation
Tu T, Song Z, Ma Y, Yang C, Su X, He C, Li G, Hong T, Sun L, Hu P, Zhang P, Ye M and Zhang H (2022) Adult dural arteriovenous fistulas in Galen region: More to be rediscovered. Front. Neurol. 13:957713. doi: 10.3389/fneur.2022.957713
Received
31 May 2022
Accepted
26 August 2022
Published
28 October 2022
Volume
13 - 2022
Edited by
Li Ma, Beijing Tiantan Hospital, Capital Medical University, China
Reviewed by
Hailiang Tang, Fudan University, China; Zongyi Xie, Chongqing Medical University, China
Updates
Copyright
© 2022 Tu, Song, Ma, Yang, Su, He, Li, Hong, Sun, Hu, Zhang, Ye and Zhang.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Peng Zhang zhangpengwr@123.comMing Ye 13911006551@163.comHongqi Zhang xwzhanghq@163.com
†These authors have contributed equally to this work and share first authorship
This article was submitted to Endovascular and Interventional Neurology, a section of the journal Frontiers in Neurology
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.